One of Richter’s most important niche areas is its Women’s Healthcare business with unique and long-term experience in this therapeutic field. The Company has consistently utilised its pharmaceutical manufacturing facilities to undertake the required complex and lengthy development processes which result in high quality gynaecological products. 
The strategic goal is to reach a leading position in geographical Europe by entering into novel WHC areas with unmet need, by offering a trendsetting portfolio and by pursuing partnering opportunities. These targets can be achieved by acquiring innovative products or late stage projects in any of the following subsegments: female fertility, uterine fibroids / endometriosis, female contraception, infectious diseases in female healthcare and HRT.